Epygen Biotech to produce recombinant Streptokinase (rSK) for the cardiovascular segment
Debayan Ghosh – President and Founder, Epygen Biotech shares insights on the current opportunities and challenges in the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
In Capex alone we will be investing around Rs 250 crores this year
USV, a 55-year old pharma company recently announced regulatory submission of proposed biosimilar Pegfilgrastim and acceptance…
69th IPC held at Chitkara University, Chandigarh
Experts discuss various steps needed for bridging gap between industry and academia
IPM clocks Rs 118554 crores in December 2017
Top 10 brands were valued at Rs 335 crores combined and grew of 13 per cent in the last month of 2017
Pharma cos prefer to work with few strategic CDMO partners
As the CDMO industry undergoes significant consolidation, Vivek Sharma, CEO, Piramal Pharma Solutions (PPS) explains to Viveka…
We are in the process of implementing a $200 million growth capex plan to expand capacity and extend…
Syngene, a major CRO in India, has been systematically investing in expanding its existing capacities as well as setting up new…
Pharma, health industry posts 59 deals worth $5 bn in Nov ’17
M&A activity was focussed in Asia-Pacific, particularly China
The pharmaceutical and healthcare industry reported 59 deals…
India Pharma 2018 to be held in Bengaluru
The event to be held from February 15-17, 2017, will be organised by DoP and FICCI
Brinton plans to become a Rs 500-cr company by 2021
Brinton Pharmaceuticals has recently forayed into the paediatric segment. Rahul Darda, CMD, Brinton Pharmaceuticals reveals more…
India Pharma 2018 to be held in Bengaluru
The event to be held from February 15-17, 2017, will be organised by DoP and FICCI